| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.15 | 0.003 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.09 | 0.07 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.086 | 0.07 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.085 | 0.09 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.074 | 0.1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.071 | 0.2 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.061 | 0.2 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.055 | 0.3 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.045 | 0.4 |